Work

Clinical benefit with compassionate use gefitinib in a subset of non-small-cell lung cancer (NSCLC) patients with the bronchoalveolar (BAC) subtype treated during an expanded access program (EAP)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7087

Authors: R. B. Reiling, J. L. Wade, R. Govindan, A. J. Wozniak, T. A. Hensing, S. Koshy, C. D. Thienelt, R. B. Natale, C. P. Belani

Institutions: Washington University in St. Louis, The Barbara Ann Karmanos Cancer Institute, Decatur Memorial Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244750051

Cites:

Cited by: 3

Related to: 10